Replies to post #430983 on Amarin Corp Plc (AMRN)

[rosemountbomber]

JRoon, there is not a single falsehood in your post, but I take a bit of an exception to the snarky last sentence. Previous management was heading along the same path, except showing less urgency in terms of cutting costs. All these things constraining the company (generic comp in the US, reticence of reimbursement in big EU countries) at this point all out of the company's hands. So I would say that shareholders voted to have someone steering the ship (with albeit a very similar course) who put their own money on the line to match ours.

[mrmainstreet]

Wow that sounds bad! Why are you still holding this stock?

[Number sleven]

JRoon, Why do you assume that cost of goods sold will continue to increase? You also assume that our margins will continue to decrease? Your statement that market share in the US will drop below 50 percent is an unsupported opinion. At the moment we don't have information about the state of the US market. Is it growing? Using the numbers you provided, non US revenue represented approximately one third of US revenue. How many quarters will it be before external markets surpass the US revenue? Concerning China, some companies are choosing not to be included in the NRDL. This way they aren't required to slash prices. I haven't seen any information about Chinese vascepa sales. I am not going to discuss imaginary numbers. I have never viewed China as a substantial source of revenue. I see that market as a tool that should help Amarin increase margins in markets we control.
I'm comfortable with the plan as I see it.
Sleven,